|
| Total (N = 583) |
| Consult Setting Inpatient Outpatient |
10/558 (1.8%) 548/558 (98.2%) |
| Hospitalization for facilitating diabetes treatment change | 3/547 (0.5%) |
| Reason for changing First Line Therapy | |
| Lack of Efficacy | 549 (94.2%) |
| Hypoglycemic Event | 25 (4.3%) |
| Weight Gain | 54 (9.3%) |
| Side Effect | 21 (3.6%) |
| Developed Acute Disease | 2 (0.3%) |
| Developed Chronic Disease | 2 (0.3%) |
| Affordability | 0 (0.0%) |
| Inability to Self-administer | 5 (0.9%) |
| Patient Request | 13 (2.2%) |
| Poor adherence | 17 (2.9%) |
| Patient convenience | 7 (1.2%) |
| Prescriber access reasons | 1 (0.2%) |
| Drug interaction | 0 (0.0%) |
| Physician preference | 9 (1.5%) |
| Reason for Choosing a Second-Line Therapy | |
| Efficacy | 508 (87.1%) |
| Tolerability | 190 (32.6%) |
| Weight | 152 (26.1%) |
| Hypoglycemic | 130 (22.3%) |
| Patient request | 28 (4.8%) |
| Convenience | 37 (6.3%) |
| Access Reason | 4 (0.7%) |
| Cost | 48 (8.2%) |
| Other | 9 (1.5%) |